Seneca Capital Investments’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-120,600
Closed -$32.8M 29
2015
Q3
$32.8M Sell
120,600
-6,334
-5% -$1.95M 11.77% 1
2015
Q2
$38.5M Sell
126,934
-24,900
-16% -$7.43M 7.22% 1
2015
Q1
$45.2M Buy
151,834
+34,234
+29% +$9.76M 10.33% 1
2014
Q4
$30.3M Buy
117,600
+15,000
+15% +$3.75M 8.36% 2
2014
Q3
$24.8M Sell
102,600
-71,400
-41% -$16M 5.42% 3
2014
Q2
$38.8M Buy
174,000
+64,000
+58% +$13.3M 6.63% 2
2014
Q1
$22.6M Buy
110,000
+35,000
+47% +$6.93M 5.34% 3
2013
Q4
$12.6M Buy
+75,000
New +$11.7M 3.17% 9

Other funds holding AGN

Seneca Capital Investments's AGN Position: Q4 2015 in Review

Seneca Capital Investments sold out of Allergan plc (AGN) in Q4 2015, closing a stake of 120,600 shares — an estimated $32.8M sold.

Seneca Capital Investments first reported a position in AGN in Q4 2013 and held it in 8 quarters. The position peaked at $45.2M in Q1 2015. 1,110 funds tracked by Wall St. Rank hold AGN as of Q4 2015.

  • Seneca Capital Investments reported no remaining Allergan plc position as of Q4 2015 after selling out during the quarter.
  • Seneca Capital Investments sold 120,600 Allergan plc shares in Q4 2015, an estimated $32.8M.
  • Seneca Capital Investments first reported a position in Allergan plc in Q4 2013 and held it in 8 quarters.
  • Seneca Capital Investments's Allergan plc position peaked at $45.2M in Q1 2015.
  • 1,110 funds tracked by Wall St. Rank held Allergan plc as of Q4 2015.

Based on Seneca Capital Investments's 13F filing for Q4 2015, filed 16 Feb 2016.